Lisata Therapeutics Inc. (LSTA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Lisata Therapeutics Inc.

    NASDAQ: LSTA · Real-Time Price · USD
    2.33
    -0.04 (-1.69%)
    At close: Sep 26, 2025, 12:47 PM

    Lisata Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 1M n/a 121.37M n/a
    Cost of Revenue
    		 174K 189K 69K 55K
    Gross Profit
    		 1M -189K 63.77M -55K
    Operating Income
    		 -22.41M -25.71M -57.6M -29.05M
    Interest Income
    		 1.88M 2.72M 1.05M 151K
    Pretax Income
    		 -20.78M -23.17M -56.7M -28.97M
    Net Income
    		 -19.98M -20.84M -54.23M -27.47M
    Selling & General & Admin
    		 12.07M 12.97M 14.14M 11.37M
    Research & Development
    		 11.33M 12.73M 43.46M 17.68M
    Other Expenses
    		 n/a -189K n/a n/a
    Operating Expenses
    		 23.41M 25.52M 57.6M 29.05M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 23.41M 25.71M 57.6M 29.05M
    Income Tax Expense
    		 -798K -2.33M -2.48M -1.51M
    Shares Outstanding (Basic)
    		 8.33M 8.07M 5.18M 3.69M
    Shares Outstanding (Diluted)
    		 8.33M 8.07M 5.18M 3.69M
    EPS (Basic)
    		 -2.4 -2.58 -10.47 -7.45
    EPS (Diluted)
    		 -2.4 -2.58 -10.47 -7.45
    EBITDA
    		 -22.23M -25.52M -56.63M -29M
    EBIT
    		 -22.41M -23.17M -56.7M -29.05M
    Depreciation & Amortization
    		 174K 189K 69K 55K

    Add to Watchlist